Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
Published November 4, 2026 · Recall initiated: October 21, 2026
Summary
FDA records drug Class II recall D-0113-2027, published November 4, 2026 and initiated October 21, 2026. Recalling firm: MSN Laboratories Private Limited (Formulations Division, Unit-II); Status: Ongoing; Reported quantity: 13,296 1,000-count bottles; Lot: Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules
What to do
Voluntary: Firm initiated · Letter
Get an email if ATORVASTATIN CALCIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- MSN Laboratories Private Limited (Formulations Division, Unit-II)
- Distributor
- Nationwide in the USA.
- UPC
- 0372205025905
- Lot
- Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDATheophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: BrandywineNovember 4, 2026
- FDABlue Bottle Coffee 4oz Sweet Blossom Simple Syrup in a glass boston round bottle with metal and plastisol cap.November 4, 2026
- FDAAtorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottleOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDCOctober 22, 2025
Questions about this recall
Was Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99 recalled?
Yes. FDA published recall D-0113-2027 on November 4, 2026. Reported hazard: Presence of Foreign Tablets/Capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0372205025905.